MAIA Biotechnology Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for MAIA Biotechnology, Inc. (MAIA) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Current Assets
Cash and Cash Equivalents9.607.1510.9510.570.66
Cash & Short-Term Investments9.607.1510.9510.570.66
Accounts Receivable0.080.140.300.040.00
Inventory0.000.000.000.000.00
Other Current Assets0.470.270.550.050.08
Total Current Assets10.157.5611.8110.670.75
Non-Current Assets
Property, Plant & Equipment (Net)0.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.00
Total Non-Current Assets0.000.000.210.650.00
Total Assets10.167.5712.0211.330.75
Current Liabilities
Accounts Payable1.511.641.170.960.15
Short-Term Debt0.000.000.000.000.01
Current Portion of Long-Term Debt0.000.000.000.000.01
Accrued Liabilities2.321.691.010.691.51
Other Current Liabilities2.320.000.000.000.00
Total Current Liabilities3.834.943.272.151.69
Non-Current Liabilities
Long-Term Debt0.000.000.000.000.43
Other Non-Current Liabilities2.692.150.250.000.24
Total Non-Current Liabilities2.692.150.250.000.00
Total Liabilities6.527.093.512.152.36
Stockholders' Equity
Common Stock0.000.000.000.000.00
Retained Earnings-87.23-63.98-44.21-28.44-15.93
Accumulated Other Comprehensive Income-0.03-0.02-0.020.000.00
Additional Paid-in Capital90.9064.4752.7337.620.00
Shares Outstanding26.1616.9910.9610.220.00
Total Stockholders' Equity3.630.488.519.18-1.62
Total Liabilities & Equity10.167.5712.0211.330.00